As of 2025-07-02, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (48.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -127.9%.
The range of the Relative Valuation is (46.44) - (47.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 18.3x | 17.5x |
| Forward P/E multiples | 17.8x - 20.5x | 19.4x |
| Fair Price | (46.44) - (47.74) | (48.13) |
| Upside | -126.9% - -127.7% | -127.9% |
| Date | P/E |